Literature DB >> 10812247

The retroviral transduction of HOXC4 into human CD34(+) cells induces an in vitro expansion of clonogenic and early progenitors.

A Daga1, M Podesta, M C Capra, G Piaggio, F Frassoni, G Corte.   

Abstract

OBJECTIVE: +HOX genes are expressed in the hematopoietic system and increasing data point to their involvement in the control of proliferation and/or differentiation. Genes belonging to the C cluster are preferentially expressed in developing and differentiated lymphoid lineages. However, recent studies demonstrated, by RT-PCR, that the HOXC4 gene is also actively transcribed in the most undifferentiated hematopoietic cells (CD34(+)38(low)) and in more mature myeloid and erythroid progenitors. We evaluated the expression of HOXC4 protein on human CD34(+) cells and the in vitro effect of its overexpression on proliferation and differentiation.
MATERIALS AND METHODS: We assessed the expression of HOXC4 on human CD34(+) cells using a polyclonal antibody raised against the C-terminal portion of the protein expressed using the baculovirus system. Overexpression of HOXC4 in human CD34(+) cells was obtained by retroviral gene transfer; its effect on clonogenic (CFU-GM, BFU-E, and CFU-GEMM) and early progenitors (LTC-IC) was evaluated.
RESULTS: The HOXC4 protein is indeed expressed in human CD34(+) cells, and its overexpression in human CD34(+) cells increases the proliferation potential of clonogenic and early progenitors. CFU-GM showed a median threefold expansion (range: 1.1-19.4; p < 0.002) compared with control transduced with the vector alone. The increment of BFU-E was higher (median ninefold, range 2.5-35; p < 0. 0009) and erythroid colonies presented a larger size with normal morphology. An even more marked effect was observed on LTC-IC (median 13, onefold; range 4.1-102.1, p < 0.0001).
CONCLUSION: We demonstrate that HOXC4 is expressed in CD34(+) cells and that its overexpression induces an in vitro expansion of committed as well as very early hematopoietic progenitors. The most striking effect was obtained on LTC-IC with an expansion of 13.1-fold. The enforced expression of HOXC4 induced a significant increase (p < 0.009) in the number of erythroid colonies compared with CFU-GM, although without perturbing, at least in vitro, the maturation program of the cells. On the other hand, the effect of the gene overexpression did not induce any skewing in the colony types derived from the myeloid lineage.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10812247     DOI: 10.1016/s0301-472x(00)00135-1

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  16 in total

1.  Analysis of HSC activity and compensatory Hox gene expression profile in Hoxb cluster mutant fetal liver cells.

Authors:  Janet Bijl; Alexander Thompson; Ramiro Ramirez-Solis; Jana Krosl; David G Grier; H Jeffrey Lawrence; Guy Sauvageau
Journal:  Blood       Date:  2005-12-08       Impact factor: 22.113

2.  NF-Ya activates multiple hematopoietic stem cell (HSC) regulatory genes and promotes HSC self-renewal.

Authors:  Jiang Zhu; Yi Zhang; Gerard J Joe; Richard Pompetti; Stephen G Emerson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-04       Impact factor: 11.205

3.  Loss of expression of the Hoxa-9 homeobox gene impairs the proliferation and repopulating ability of hematopoietic stem cells.

Authors:  H Jeffrey Lawrence; Julie Christensen; Stephen Fong; Yu-Long Hu; Irving Weissman; Guy Sauvageau; R Keith Humphries; Corey Largman
Journal:  Blood       Date:  2005-08-09       Impact factor: 22.113

4.  Differential methylation in CN-AML preferentially targets non-CGI regions and is dictated by DNMT3A mutational status and associated with predominant hypomethylation of HOX genes.

Authors:  Ying Qu; Andreas Lennartsson; Verena I Gaidzik; Stefan Deneberg; Mohsen Karimi; Sofia Bengtzén; Martin Höglund; Lars Bullinger; Konstanze Döhner; Sören Lehmann
Journal:  Epigenetics       Date:  2014-05-27       Impact factor: 4.528

5.  Hemgn is a direct transcriptional target of HOXB4 and induces expansion of murine myeloid progenitor cells.

Authors:  Jie Jiang; Hui Yu; Yan Shou; Geoffrey Neale; Sheng Zhou; Taihe Lu; Brian P Sorrentino
Journal:  Blood       Date:  2010-04-14       Impact factor: 22.113

6.  HOXC4 homeoprotein efficiently expands human hematopoietic stem cells and triggers similar molecular alterations as HOXB4.

Authors:  Céline Auvray; Andrée Delahaye; Françoise Pflumio; Rima Haddad; Sophie Amsellem; Ayda Miri-Nezhad; Loïc Broix; Azzedine Yacia; Frédérique Bulle; Serge Fichelson; Isabelle Vigon
Journal:  Haematologica       Date:  2012-02       Impact factor: 9.941

7.  HOXA9 is required for survival in human MLL-rearranged acute leukemias.

Authors:  Joerg Faber; Andrei V Krivtsov; Matthew C Stubbs; Renee Wright; Tina N Davis; Marry van den Heuvel-Eibrink; Christian M Zwaan; Andrew L Kung; Scott A Armstrong
Journal:  Blood       Date:  2008-12-03       Impact factor: 22.113

8.  Model systems for examining effects of leukemia-associated oncogenes in primary human CD34+ cells via retroviral transduction.

Authors:  Mark Wunderlich; James C Mulloy
Journal:  Methods Mol Biol       Date:  2009

9.  Polycomb repressive complex 2 regulates normal hematopoietic stem cell function in a developmental-stage-specific manner.

Authors:  Huafeng Xie; Jian Xu; Jessie H Hsu; Minh Nguyen; Yuko Fujiwara; Cong Peng; Stuart H Orkin
Journal:  Cell Stem Cell       Date:  2013-11-14       Impact factor: 24.633

10.  Reduced proliferative capacity of hematopoietic stem cells deficient in Hoxb3 and Hoxb4.

Authors:  Jon Mar Björnsson; Nina Larsson; Ann C M Brun; Mattias Magnusson; Elisabet Andersson; Patrik Lundström; Jonas Larsson; Ewa Repetowska; Mats Ehinger; R Keith Humphries; Stefan Karlsson
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.